• Je něco špatně v tomto záznamu ?

Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptors

S. Bazua-Valenti, MR. Brown, J. Zavras, M. Riedl Khursigara, E. Grinkevich, EH. Sidhom, KH. Keller, M. Racette, M. Dvela-Levitt, C. Quintanova, H. Demirci, S. Sewerin, AC. Goss, J. Lin, H. Yoo, AS. Vaca Jacome, M. Papanastasiou, N. Udeshi, SA....

. 2024 ; 134 (24) : . [pub] 20241216

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003024

Grantová podpora
K00 DK123834 NIDDK NIH HHS - United States
S10 OD026839 NIH HHS - United States

The trafficking dynamics of uromodulin (UMOD), the most abundant protein in human urine, play a critical role in the pathogenesis of kidney disease. Monoallelic mutations in the UMOD gene cause autosomal dominant tubulointerstitial kidney disease (ADTKD-UMOD), an incurable genetic disorder that leads to kidney failure. The disease is caused by the intracellular entrapment of mutant UMOD in kidney epithelial cells, but the precise mechanisms mediating disrupted UMOD trafficking remain elusive. Here, we report that transmembrane Emp24 protein transport domain-containing (TMED) cargo receptors TMED2, TMED9, and TMED10 bind UMOD and regulate its trafficking along the secretory pathway. Pharmacological targeting of TMEDs in cells, in human kidney organoids derived from patients with ADTKD-UMOD, and in mutant-UMOD-knockin mice reduced intracellular accumulation of mutant UMOD and restored trafficking and localization of UMOD to the apical plasma membrane. In vivo, the TMED-targeted small molecule also mitigated ER stress and markers of kidney damage and fibrosis. Our work reveals TMED-targeting small molecules as a promising therapeutic strategy for kidney proteinopathies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003024
003      
CZ-PrNML
005      
20250206104018.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1172/JCI180347 $2 doi
035    __
$a (PubMed)39680459
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bazua-Valenti, Silvana $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA $u Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA $u Departamento de Nefrología y Metabolismo Mineral, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México
245    10
$a Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptors / $c S. Bazua-Valenti, MR. Brown, J. Zavras, M. Riedl Khursigara, E. Grinkevich, EH. Sidhom, KH. Keller, M. Racette, M. Dvela-Levitt, C. Quintanova, H. Demirci, S. Sewerin, AC. Goss, J. Lin, H. Yoo, AS. Vaca Jacome, M. Papanastasiou, N. Udeshi, SA. Carr, N. Himmerkus, M. Bleich, K. Mutig, S. Bachmann, J. Halbritter, S. Kmoch, M. Živná, K. Kidd, AJ. Bleyer, A. Weins, SL. Alper, JL. Shaw, M. Kost-Alimova, JLB. Pablo, A. Greka
520    9_
$a The trafficking dynamics of uromodulin (UMOD), the most abundant protein in human urine, play a critical role in the pathogenesis of kidney disease. Monoallelic mutations in the UMOD gene cause autosomal dominant tubulointerstitial kidney disease (ADTKD-UMOD), an incurable genetic disorder that leads to kidney failure. The disease is caused by the intracellular entrapment of mutant UMOD in kidney epithelial cells, but the precise mechanisms mediating disrupted UMOD trafficking remain elusive. Here, we report that transmembrane Emp24 protein transport domain-containing (TMED) cargo receptors TMED2, TMED9, and TMED10 bind UMOD and regulate its trafficking along the secretory pathway. Pharmacological targeting of TMEDs in cells, in human kidney organoids derived from patients with ADTKD-UMOD, and in mutant-UMOD-knockin mice reduced intracellular accumulation of mutant UMOD and restored trafficking and localization of UMOD to the apical plasma membrane. In vivo, the TMED-targeted small molecule also mitigated ER stress and markers of kidney damage and fibrosis. Our work reveals TMED-targeting small molecules as a promising therapeutic strategy for kidney proteinopathies.
650    12
$a uromodulin $x metabolismus $x genetika $7 D058949
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
650    _2
$a myši $7 D051379
650    12
$a transport proteinů $7 D021381
650    _2
$a mutace $7 D009154
650    _2
$a membránové glykoproteiny $x metabolismus $x genetika $7 D008562
655    _2
$a časopisecké články $7 D016428
700    1_
$a Brown, Matthew R $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Zavras, Jason $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Riedl Khursigara, Magdalena $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Grinkevich, Elizabeth $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Sidhom, Eriene-Heidi $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA $u Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
700    1_
$a Keller, Keith H $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA $u Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
700    1_
$a Racette, Matthew $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Dvela-Levitt, Moran $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA $u The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel
700    1_
$a Quintanova, Catarina $u Institute of Physiology, Christian - Albrechts - Universität, Kiel, Germany
700    1_
$a Demirci, Hasan $u Institute of Translational Physiology and $u Department of Anatomy, Charité - Universitätsmedizin, Berlin, Germany
700    1_
$a Sewerin, Sebastian $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Goss, Alissa C $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA $u Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
700    1_
$a Lin, John $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Yoo, Hyery $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Vaca Jacome, Alvaro S $u Proteomics Platform, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Papanastasiou, Malvina $u Proteomics Platform, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Udeshi, Namrata $u Proteomics Platform, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Carr, Steven A $u Proteomics Platform, The Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Himmerkus, Nina $u Institute of Physiology, Christian - Albrechts - Universität, Kiel, Germany
700    1_
$a Bleich, Markus $u Institute of Physiology, Christian - Albrechts - Universität, Kiel, Germany
700    1_
$a Mutig, Kerim $u Institute of Translational Physiology and $u Department of Anatomy, Charité - Universitätsmedizin, Berlin, Germany
700    1_
$a Bachmann, Sebastian $u Institute of Translational Physiology and $u Department of Anatomy, Charité - Universitätsmedizin, Berlin, Germany
700    1_
$a Halbritter, Jan $u Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin, Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
700    1_
$a Kmoch, Stanislav $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Živná, Martina $u Research Unit for Rare Diseases, Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Kidd, Kendrah $u Section on Nephrology, Wake Forest School of Medicine, Medical Center Blvd., Winston-Salem, North Carolina, USA
700    1_
$a Bleyer, Anthony J $u Section on Nephrology, Wake Forest School of Medicine, Medical Center Blvd., Winston-Salem, North Carolina, USA
700    1_
$a Weins, Astrid $u Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
700    1_
$a Alper, Seth L $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA $u Division of Nephrology, Beth Israel Deaconess Medical Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
700    1_
$a Shaw, Jillian L $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Kost-Alimova, Maria $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Pablo, Juan Lorenzo B $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
700    1_
$a Greka, Anna $u The Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA $u Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
773    0_
$w MED00002590 $t The Journal of clinical investigation $x 1558-8238 $g Roč. 134, č. 24 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39680459 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104014 $b ABA008
999    __
$a ok $b bmc $g 2263048 $s 1239031
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 134 $c 24 $e 20241216 $i 1558-8238 $m The Journal of clinical investigation $n J Clin Invest $x MED00002590
GRA    __
$a K00 DK123834 $p NIDDK NIH HHS $2 United States
GRA    __
$a S10 OD026839 $p NIH HHS $2 United States
LZP    __
$a Pubmed-20250121
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace